FdaApplication
ANDA 213637
Identifiers
- fda_app_no: ANDA213637
Properties
| Property | Value |
|---|---|
| applicant_name | BWXT MEDICAL LTD |
| application_type | ANDA |
| approval_date | 2024-12-09 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| IOBENGUANE I-123 | IOBENGUANE SULFATE I-123 | 10mCi/5ML (2mCi/ML) | SOLUTION;INTRAVENOUS |
1 product